Gozdecka, Malgorzata https://orcid.org/0000-0002-3134-1276
Dudek, Monika
Wen, Sean
Gu, Muxin
Stopforth, Richard J. https://orcid.org/0000-0002-0054-7503
Rak, Justyna
Damaskou, Aristi
Grice, Guinevere L.
McLoughlin, Matthew A. https://orcid.org/0000-0002-4782-5718
Bond, Laura https://orcid.org/0000-0001-6115-655X
Wilson, Rachael https://orcid.org/0000-0001-5129-7295
Giotopoulos, George https://orcid.org/0000-0003-1390-6592
Shanmugiah, Vijaya Mahalingam
Bakar, Rula Bany https://orcid.org/0000-0002-5643-0195
Yankova, Eliza https://orcid.org/0000-0003-2913-0012
Cooper, Jonathan L.
Narayan, Nisha https://orcid.org/0000-0002-4106-2166
Horton, Sarah J. https://orcid.org/0000-0001-8418-5783
Asby, Ryan
Pask, Dean C.
Mupo, Annalisa
Duddy, Graham
Marando, Ludovica
Georgomanolis, Theodoros
Carter, Paul
Ramesh, Amirtha Priya
Dunn, William G.
Barcena, Clea https://orcid.org/0000-0002-7452-2536
Gallipoli, Paolo https://orcid.org/0000-0001-7254-2253
Yusa, Kosuke
Petrovski, Slavé
Wright, Penny
Quiros, Pedro M. https://orcid.org/0000-0002-7793-6291
Frezza, Christian https://orcid.org/0000-0002-3293-7397
Nathan, James A. https://orcid.org/0000-0002-0248-1632
Kaser, Arthur https://orcid.org/0000-0003-1419-3344
Kar, Siddhartha
Tzelepis, Konstantinos https://orcid.org/0000-0002-4865-7648
Mitchell, Jonathan https://orcid.org/0000-0003-3792-4058
Fabre, Margarete A. https://orcid.org/0000-0001-7794-610X
Huntly, Brian J. P. https://orcid.org/0000-0003-0312-161X
Vassiliou, George S. https://orcid.org/0000-0003-4337-8022
Article History
Received: 19 March 2024
Accepted: 4 April 2025
First Online: 16 April 2025
Competing interests
: G.S.V. is a consultant for STRM.BIO and receives a research grant from AstraZeneca. S.W., J.M. and M.A.F. are current employees and/or stockholders of AstraZeneca. K.T. has received consultancy fees, stock options and research funding from Storm Therapeutics Ltd., Cambridge, UK. K.T. is a cofounder of Btwo3 Therapeutics LLC, USA and TEP Therapeutics LLC, USA. The other authors declare no competing interests.